Moya-Salazar, J.; Terán-Vásquez, A.; Salazar-Hernandez, R.; Rojas-Zumaran, V.; Goicochea-Palomino, E.A.; Moya-Salazar, M.M.; Contreras-Pulache, H.
In Vitro Therapeutic Efficacy of Furazolidone for Antimicrobial Susceptibility Testing on Campylobacter. Antibiotics 2025, 14, 636.
https://doi.org/10.3390/antibiotics14070636
AMA Style
Moya-Salazar J, Terán-Vásquez A, Salazar-Hernandez R, Rojas-Zumaran V, Goicochea-Palomino EA, Moya-Salazar MM, Contreras-Pulache H.
In Vitro Therapeutic Efficacy of Furazolidone for Antimicrobial Susceptibility Testing on Campylobacter. Antibiotics. 2025; 14(7):636.
https://doi.org/10.3390/antibiotics14070636
Chicago/Turabian Style
Moya-Salazar, Jeel, Alfonso Terán-Vásquez, Richard Salazar-Hernandez, VÃctor Rojas-Zumaran, Eliane A. Goicochea-Palomino, Marcia M. Moya-Salazar, and Hans Contreras-Pulache.
2025. "In Vitro Therapeutic Efficacy of Furazolidone for Antimicrobial Susceptibility Testing on Campylobacter" Antibiotics 14, no. 7: 636.
https://doi.org/10.3390/antibiotics14070636
APA Style
Moya-Salazar, J., Terán-Vásquez, A., Salazar-Hernandez, R., Rojas-Zumaran, V., Goicochea-Palomino, E. A., Moya-Salazar, M. M., & Contreras-Pulache, H.
(2025). In Vitro Therapeutic Efficacy of Furazolidone for Antimicrobial Susceptibility Testing on Campylobacter. Antibiotics, 14(7), 636.
https://doi.org/10.3390/antibiotics14070636
